|
Mutation Information
|
Mutation Site
|
V173L |
|
Mutation Type
|
Amino acid level |
|
Gene/Protein/Region Type
|
RT |
|
Combined Mutation
|
rt.V173L+rt.L180M+rt.M204V |
|
Genotype/Subtype
|
B;C;D |
|
Relevant Drug
|
lamivudine (LAM) |
|
Country
|
China |
Literature Information
|
PubMed PMID
|
21392168
|
|
Disease
|
Chronic hepatitis B;
Liver cirrhosis
|
|
Published Year
|
2011 |
|
Journal
|
Journal of viral hepatitis |
|
Title
|
Genotypic resistance profile of hepatitis B virus (HBV) in a large cohort of nucleos(t)ide analogue-experienced Chinese patients with chronic HBV infection. |
|
Author
|
Liu Y,Wang C,Zhong Y,Li X,Dai J,Ren X,Xu Z,Li L,Yao Z,Ji D,Wang L,Zhang L,Wong VW,Zoulim F,Xu D |
|
Evidence
|
O received monotherapies, rtM204I (32.2%), rtM204V + L180M +- V173L (32.2%) and rtM204I + L180M +- V173L (21.0%) were dominant patterns for LAM; rtN236T + A181T and/or rtA181V (34.3%), rtN236T (31.4%) and rtA181V (28.6%) were dominant patterns for ADV, and mutations containing rtM204I were dominant patterns for LdT.
|
|
|
HBV Mutation Detail Information